FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi

4 months ago 108

Signage outside Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025.

Kyle Grillot | Bloomberg | Getty Images